Quick Takeaways
- Contrarius Investment Management Ltd filed SCHEDULE 13G for INTELLIA THERAPEUTICS, INC COMMON STOCK (NTLA).
- Disclosed ownership: 5.5%.
- Date of event: 30 Sep 2025.
Contrarius Investment Management Ltd - 30 Sep 2025 SCHEDULE 13G Report for INTELLIA THERAPEUTICS, INC COMMON STOCK (NTLA)
- Filing Manager
- Contrarius Investment Management Ltd
- Reporting Manager
- Contrarius Investment Management Ltd
- Symbol
- NTLA
- Shares outstanding
- 107,089,745 shares
- Disclosed Ownership
- 5,889,936 shares
- Ownership
- 5.5%
- Form type
- SCHEDULE 13G
- Filing time
- 12 Nov 2025, 13:47:50 UTC
- Date of event
- 30 Sep 2025
- Next filing
- 11 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Contrarius Investment Management Ltd disclosed 5.5% ownership in INTELLIA THERAPEUTICS, INC COMMON STOCK (NTLA) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Nov 2025, 13:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Contrarius Investment Management Ltd | 5.5% | 5,889,936 | 0 | 5,889,936 | /s/ Thomas Daniel Perkins | Thomas Daniel Perkins / Director | |
| Contrarius Investment Management (Bermuda) Ltd | 5.5% | 5,889,936 | 0 | 5,889,936 | /s/ Matt De Kock | Matt De Kock / Director |